Exscientia PLC (EXAI)
5.03
+0.27
(+5.67%)
USD |
NASDAQ |
Jun 14, 16:00
5.00
-0.03
(-0.60%)
After-Hours: 20:00
Exscientia EPS Diluted (Quarterly): -0.2156 for March 31, 2024
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -0.2156 |
| December 31, 2023 | -0.4095 |
| September 30, 2023 | -0.3166 |
| June 30, 2023 | -0.363 |
| March 31, 2023 | -0.3768 |
| December 31, 2022 | -0.3692 |
| September 30, 2022 | -0.3413 |
| June 30, 2022 | -0.3017 |
| Date | Value |
|---|---|
| March 31, 2022 | -0.1744 |
| December 31, 2021 | -0.9089 |
| September 30, 2021 | -0.0594 |
| June 30, 2021 | -0.2205 |
| March 31, 2021 | -0.0001 |
| December 31, 2020 | -0.0001 |
| September 30, 2020 | -0.0001 |
Earnings per Share Definition
Earnings per share measures the total net income / average shares outstanding during income period. There are a few variations to earnings per share that are listed including "EPS Basic", "EPS Diluted", "Normalized Basic EPS", and "Normalized Diluted EPS". Each of these metrics are dependent on which earnings and shares outstanding metrics are used. Basic and Diluted EPS differ in that diluted shares are the amount of shares outstanding after all convertible securities, options, and warrants are exercised. Normalized EPS allows does not include one-time expenses.
EPS Diluted (Quarterly) Range, Past 5 Years
-0.9089
Minimum
Dec 2021
-0.0001
Maximum
Mar 2021
-0.2705
Average
-0.3017
Median
Jun 2022
EPS Diluted (Quarterly) Benchmarks
| Akero Therapeutics Inc | -0.90 |
| Adaptimmune Therapeutics PLC | -0.18 |
| Biodexa Pharmaceuticals Plc | -- |
| Verona Pharma PLC | -0.32 |
| NuCana PLC | -4.122 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -26.65M |
| Revenue (Quarterly) | 6.710M |
| Total Expenses (Quarterly) | 42.06M |
| Enterprise Value | 410.49M |
| Gross Profit Margin (Quarterly) | -40.02% |
| Profit Margin (Quarterly) | -397.1% |
| Earnings Yield | -25.94% |
| Normalized Earnings Yield | -26.03 |